This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Natus Medical Valuation

Q: What is the Fair Price of NTUS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

NTUS ($32.96) is trading above our estimate of [[fair value]] ($19.02)

Is NTUS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NTUS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NTUS ($32.96) is trading above our estimate of fair value ($19.02)

Significantly Below Fair Value: NTUS is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NTUS?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for NTUS. This is calculated by dividing NTUS's market cap by their current preferred multiple.
What is NTUS's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	US$1.13b

NTUS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.2x
Enterprise Value/EBITDA	18.1x
PEG Ratio	1.5x

Price to Earnings Ratio vs Peers

How does NTUS's PE Ratio compare to its peers?

The above table shows the PE ratio for NTUS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	40.5x
LMAT LeMaitre Vascular	48.3x	14.0%	US$1.5b
VREX Varex Imaging	14.8x	10.7%	US$660.1m
NUVA NuVasive	73.3x	46.2%	US$2.1b
CNMD CONMED	25.4x	27.7%	US$2.1b
NTUS Natus Medical	89x	58.9%	US$1.1b

Price-To-Earnings vs Peers: NTUS is expensive based on its Price-To-Earnings Ratio (89x) compared to the peer average (28.1x).

Price to Earnings Ratio vs Industry

How does NTUS's PE Ratio compare vs other companies in the US Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	16.1%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	16.1%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: NTUS is expensive based on its Price-To-Earnings Ratio (89x) compared to the US Medical Equipment industry average (34.3x)

Price to Earnings Ratio vs Fair Ratio

What is NTUS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NTUS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	89x
Fair PE Ratio	74x

Price-To-Earnings vs Fair Ratio: NTUS is expensive based on its Price-To-Earnings Ratio (89x) compared to the estimated Fair Price-To-Earnings Ratio (74x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.